Molecular Diagnostics
New Diagnostic Test 1,000 Times More Sensitive than Conventional Tests
In their effort to overcome the limitations of point-of-care diagnostic tests, researchers have now developed ultrabright fluorescent nanolabels called plasmonic-fluors, which can be quickly integrated into the lateral flow assay (LFA), a common testing platform. Plasmon-enhanced LFAs (p-LFAs) improve inexpensive, readily available rapid tests to the levels of sensitivity required by physicians for confidence in test results without the need for lab-based confirmation. More...13 Feb 2023
Unique Biomarker Could Lead to Diagnostic Tests for Detection of Early-Stage Alzheimer’s
Researchers have identified a new protein in the cerebrospinal fluid that can reliably detect endothelial injury in patients with Alzheimer’s disease. Using this biomarker, they found that endothelial injury is a key contributor to cognitive impairment during the earliest pre-symptomatic stages of the disease as well. More...10 Feb 2023
Voice-Activated Sample Pre-Treatment Device Enables Hands-Free, Safer DNA Handling
Scientists using samples containing pathogens work with the smallest amounts possible in order to avoid accidental infection. Now, the same technology used by smart voice assistants could also make the laboratory a safer place for scientists and technicians handling infectious samples. More...10 Feb 2023
World’s First AI-Powered Diagnostic Test Accurately Identifies Respiratory Viruses in Five Minutes
A world-first diagnostic test powered by AI that can identify known respiratory viruses within five minutes from just one nasal or throat swab could replace current testing methods which are limited to testing for just one infection or are either lab-based and time-consuming or fast and less accurate. More...09 Feb 2023
New Blood Test Detects Prostate Cancer With 94% Accuracy
Prostate cancer is the most common cancer in men, creating the need for a blood test that can detect it with greater accuracy. Now, new research shows that the (Prostate Screening EpiSwitch) ‘PSE’ blood test is 94% accurate and much superior than the currently used prostate-specific antigen (PSA) blood test. More...09 Feb 2023
World’s First Comprehensive Risk Test for Breast & Ovarian Cancer Launched
The world’s first comprehensive risk assessment test can evaluate a woman’s risk of developing breast and/or ovarian cancer either from a hereditary genetic mutation or from the far more common familial or sporadic cancer. Combined with other clinical risk factors, the test provides a comprehensive risk assessment in a simple saliva test. More...08 Feb 2023
New Assay Determines if Bladder Cancer Patients Need Radical Surgery
A new assay tested in patients with muscle-invasive bladder cancer immediately following treatment with a combination of the immune checkpoint inhibitors in the neoadjuvant setting has demonstrated clinical potential for helping oncologists determine whether or not the patients need to undergo radical surgery. More...08 Feb 2023
Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
.jpg)
Gold Member
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)
In Other News
Urine Prostate Cancer Screening Test Offers Best-In-Class Accuracy and Stratified Risk Assessment
Nanotechnology-Based Blood Test Could Revolutionize Prostate Cancer Diagnosis
New Device Detects Brain Tumors Using Urine
New Blood Test Could Ensure Timely Life-Saving Treatment of Heart Attack Victims
Real-Time PCR System Advances Large Reaction Volume IVD Assay Development and Diagnostic Testing
Focused-Ultrasound-Mediated Liquid Biopsy to Facilitate Diagnosis of Neurodegenerative Disorders
Blood Test Predicts Alzheimer's Risk 3.5 Years Before Clinical Diagnosis
Novel Biomarker-Based Tests to Predict Response to Drugs for Treatment of Chronic Kidney Disease
Newly Identified Protein Biomarkers in Blood Predict Sudden Cardiac Arrest Before it Strikes
Blood Test Identifies Osteoarthritis Progression More Accurately than Current Methods
New DNA Biosensor Could Make High-Quality Clinical Diagnostics More Accessible
New Technique Enables Measurement of Thousands of Molecules from Single Blood Drop
Non-Invasive Blood Test Helps Select Treatment for Advanced Gastrointestinal Stromal Tumors
Non-Invasive Melanoma Test Ushers in New Era in Skin Cancer Detection
World’s First Molecular, Cell-Based Test Offers Non-Surgical Method for Diagnosis and Staging of Endometriosis
Rapid POC Diagnostic Assay Could Detect and Measure Fentanyl Neutralizing Antibodies
Molecular Diagnostic Platform for Automated Sample Processing to Help Labs Achieve New Flexibility Level
Early Alzheimer’s Detection Sensor Could Also Diagnose Other Diseases at POC
First-Of-A-Kind Pan-Cancer Blood Test Could Predict Immunotherapy Efficacy and Toxicity
World’s First Test Detects Diabetics at Risk of Kidney Disease before Symptoms Appear
ELISAs Reliably Detect Anti-CCHFV Antibodies in Acute Infections
New Blood Test Tracks and Follows Neurodegeneration in Alzheimer's
Electrochemical Cell-Free Biosensor Directly Detects Influenza Antibodies in Blood at POC
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.